DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF A VASOPRESSIN V2-RECEPTOR ANTAGONIST IN PATIENTS WITH SCHIZOPHRENIA AND HYPONATREMIA
Richard Josiassen, Morris Goldman, Meera Jessani, Rita A. Shaughnessy, Frank Czerwick, Cesare OrlandiVolume:
102
Year:
2008
Language:
english
DOI:
10.1016/s0920-9964(08)70768-0
File:
PDF, 61 KB
english, 2008